Result of AGM
Fusion Antibodies PLC announced that all resolutions were duly passed at the annual general meeting held on October 16, 2025. Full details of the voting results will be available on the Company's website.
Select text to share a quote on X · sign in to keep highlights & notes in your FAB notes
Fusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, announces that at the annual general meeting ("AGM") held earlier today, all resolutions were duly passed.
Full details of the voting results will be available on the Company's website here.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.